Literature DB >> 24698301

Increased prevalence and altered species composition of filamentous fungi in respiratory specimens from cystic fibrosis patients.

Signe M Nielsen1, Lise Kristensen, Annette Søndergaard, Kurt J Handberg, Jørgen Stenderup, Niels Nørskov-Lauritsen.   

Abstract

Filamentous fungi cultured from respiratory tract specimens submitted to the department of clinical microbiology, Aarhus University Hospital, during 2010 were identified by morphology and by internal transcribed spacer (ITS) sequencing. Of 343 fungal isolates, discrepancies between identification methods were observed for four isolates (1.2%), while identification to species was achieved only with ITS sequencing for 16 isolates (4.7%). Filamentous fungi were isolated from 15% of cystic fibrosis (CF) respiratory samples in contrast to 2% of non-CF samples. From CF patients, a total of nine different species were found in 188 samples from 48 patients, whereas from non-CF patients, 24 different species were found in 155 samples from 111 patients. CF was associated with a significant overrepresentation of Aspergillus fumigatus and Scedosporium species; in contrast, the frequency of Penicillium spp. and other putative contaminants were significantly increased in non-CF patients. The altered species variation of filamentous fungi in CF respiratory specimens is contradictory to a scenario of incidentally inhaled spores, trapped in the viscous airway mucus of these patients and subsequently expectorated; rather, our data most likely reflect both an increased prevalence and an increased proportion of truly colonizing fungi in this patient group.
© 2014 APMIS. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Cystic fibrosis; ITS sequencing; Scedosporium; identification discrepancies

Mesh:

Year:  2014        PMID: 24698301     DOI: 10.1111/apm.12253

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  3 in total

Review 1.  Proteomics as a Tool to Identify New Targets Against Aspergillus and Scedosporium in the Context of Cystic Fibrosis.

Authors:  Andoni Ramirez-Garcia; Aize Pellon; Idoia Buldain; Aitziber Antoran; Aitana Arbizu-Delgado; Xabier Guruceaga; Aitor Rementeria; Fernando L Hernando
Journal:  Mycopathologia       Date:  2017-05-08       Impact factor: 2.574

2.  Aspergillus Bronchitis in Patients with Cystic Fibrosis.

Authors:  Claudia Brandt; Jobst Roehmel; Volker Rickerts; Volker Melichar; Nadja Niemann; Carsten Schwarz
Journal:  Mycopathologia       Date:  2017-08-17       Impact factor: 2.574

3.  Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study.

Authors:  Noémie Coron; Marc Pihet; Emilie Fréalle; Yolande Lemeille; Claudine Pinel; Hervé Pelloux; Gilles Gargala; Loic Favennec; Isabelle Accoceberry; Isabelle Durand-Joly; Frédéric Dalle; Frédéric Huet; Annlyse Fanton; Amale Boldron; Guy-André Loeuille; Philippe Domblides; Bérengère Coltey; Isabelle Pin; Catherine Llerena; Françoise Troussier; Christine Person; Christophe Marguet; Nathalie Wizla; Caroline Thumerelle; Dominique Turck; Stéphanie Bui; Michael Fayon; Alain Duhamel; Anne Prévotat; Benoit Wallaert; Sylvie Leroy; Jean-Philippe Bouchara; Laurence Delhaes
Journal:  Mycopathologia       Date:  2017-07-26       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.